118 related articles for article (PubMed ID: 3276890)
1. Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.
Sham HL; Bolis G; Stein HH; Fesik SW; Marcotte PA; Plattner JJ; Rempel CA; Greer J
J Med Chem; 1988 Feb; 31(2):284-95. PubMed ID: 3276890
[TBL] [Abstract][Full Text] [Related]
2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of renin by conformationally restricted analogues of angiotensinogen.
Nakaie CR; Oliveira MC; Juliano L; Paiva AC
Biochem J; 1982 Jul; 205(1):43-7. PubMed ID: 6751323
[TBL] [Abstract][Full Text] [Related]
4. Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.
Thaisrivongs S; Blinn JR; Pals DT; Turner SR
J Med Chem; 1991 Apr; 34(4):1276-82. PubMed ID: 2016704
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
[TBL] [Abstract][Full Text] [Related]
9. Conformational aspects of angiotensinogen analogues with renin inhibitory activity.
Liepina I; Nikiforovich GV; Paiva AC
Biochem Biophys Res Commun; 1984 Jul; 122(2):700-5. PubMed ID: 6380499
[TBL] [Abstract][Full Text] [Related]
10. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors.
Weber AE; Halgren TA; Doyle JJ; Lynch RJ; Siegl PK; Parsons WH; Greenlee WJ; Patchett AA
J Med Chem; 1991 Sep; 34(9):2692-701. PubMed ID: 1895289
[TBL] [Abstract][Full Text] [Related]
13. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
[TBL] [Abstract][Full Text] [Related]
14. New renin inhibitors--stability and activity determination. Part I.
Marszałek D; Goldnik A; Mazurek AP; Winiecka I; Jaworskpi P
Acta Pol Pharm; 2014; 71(4):545-53. PubMed ID: 25272881
[TBL] [Abstract][Full Text] [Related]
15. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
16. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.
Plattner JJ; Greer J; Fung AK; Stein H; Kleinert HD; Sham HL; Smital JR; Perun TJ
Biochem Biophys Res Commun; 1986 Sep; 139(3):982-90. PubMed ID: 3533075
[TBL] [Abstract][Full Text] [Related]
17. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp.
Dutta AS; Gormley JJ; McLachlan PF; Major JS
J Med Chem; 1990 Sep; 33(9):2552-60. PubMed ID: 2202828
[TBL] [Abstract][Full Text] [Related]
19. Highly potent and specific inhibitors of human renin.
Kokubu T; Hiwada K; Murakami E; Imamura Y; Matsueda R; Yabe Y; Koike H; Iijima Y
Hypertension; 1985; 7(3 Pt 2):I8-11. PubMed ID: 2987128
[TBL] [Abstract][Full Text] [Related]
20. NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART III.
Marszałek D; Goldnik A; Winiecka I; Jaworski P; Mazurek AP
Acta Pol Pharm; 2016; 73(2):329-36. PubMed ID: 27180425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
